Stargardt macular degeneration
Clinical trials for Stargardt macular degeneration explained in plain language.
Never miss a new study
Get alerted when new Stargardt macular degeneration trials appear
Sign up with your email to follow new studies for Stargardt macular degeneration, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Modified vitamin a pill tested against inherited blindness
Disease control OngoingResearchers are testing whether a daily pill called ALK-001 can slow the progression of Stargardt disease, a rare inherited condition that causes vision loss in children and young adults. The trial enrolls people aged 8 and older who have a clinical diagnosis of Stargardt disease…
Matched conditions: STARGARDT MACULAR DEGENERATION
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC
-
Vitamin a derivative eyed to halt inherited blindness
Disease control OngoingResearchers are testing a daily oral drug called ALK-001 in people aged 8 to 70 with Stargardt disease, an inherited condition that causes progressive vision loss. The trial compares ALK-001 to a placebo over 24 months to see if the drug is safe and can slow damage to the retina.…
Matched conditions: STARGARDT MACULAR DEGENERATION
Phase 2 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 21, 2026 23:00 UTC